The Enteroinsular Axis — Why Multiplex Measurement Matters

The gut-brain-pancreas axis is a coordinated hormonal network: nutrient ingestion triggers L-cell secretion of GLP-1 and PYY, which potentiate glucose-stimulated insulin secretion (the incretin effect) while suppressing glucagon and slowing gastric emptying. Simultaneously, gastric X/A-like cells secrete ghrelin to stimulate appetite, while adipose tissue releases leptin to signal long-term energy stores. These hormones do not act independently — their ratios, temporal dynamics, and coordinated responses to physiological challenges carry more biological information than any single hormone concentration.

Key Metabolic Hormones — Biological Roles and Research Relevance

  • Insulin: Pancreatic β-cell hormone; the primary anabolic signal. Fasting levels reflect insulin sensitivity; postprandial or glucose-stimulated levels reflect β-cell function. Must be interpreted together with glucagon (insulin:glucagon ratio) and C-peptide (distinguishes endogenous from exogenous insulin).
  • Glucagon: Pancreatic α-cell hormone; counter-regulatory to insulin — stimulates hepatic glucose output. Dysregulated in type 2 diabetes (failure of glucose-induced glucagon suppression). Requires protease inhibitor-stabilized collection due to rapid ex vivo degradation.
  • GLP-1 (Active & Total): L-cell incretin hormone; potentiates insulin secretion, suppresses glucagon, delays gastric emptying. Active form (7-36 amide) engages the GLP-1R; total assay captures both active and DPP-IV-cleaved inactive forms. Central to incretin biology, DPP-IV inhibitor pharmacology, and GLP-1R agonist development.
  • GIP (Active & Total): K-cell incretin hormone; insulinotropic effects dependent on metabolic state. The second major incretin alongside GLP-1. GIPR agonists in active development for obesity and diabetes.
  • C-Peptide: Cleaved from proinsulin during insulin maturation; secreted in equimolar amounts with endogenous insulin but not present in exogenous insulin preparations. Essential for distinguishing endogenous insulin secretion from administered insulin in research participants receiving insulin therapy.
  • Leptin: Adipocyte hormone; signals long-term energy stores to the hypothalamus. Leptin resistance is a hallmark of obesity. Concentrations span three orders of magnitude from lean to obese — requiring wide dynamic range.
  • PYY (Total): L-cell hormone co-secreted with GLP-1; suppresses appetite via hypothalamic Y2 receptors. Dramatically elevated after bariatric surgery and implicated in surgically induced weight loss.
  • Ghrelin (Active & Total): Gastric X/A-like cell hormone; the only known orexigenic gut peptide. Active ghrelin requires octanoylation at Ser3 for GHS-R1a receptor activation. Total ghrelin captures both acylated and des-acyl forms.
  • Pancreatic Polypeptide (PP): PP-cell hormone; regulates pancreatic exocrine secretion and gastric motility. Surrogate marker of vagal tone. Elevated in pancreatic neuroendocrine tumors (research context).